Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Bicycle Therapeutics PLC

NASDAQ: BCYC · Life Sciences · 4 alerts · CIK 1761612

Share price
$3.18Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Bicycle Therapeutics PLC filings on SEC EDGAR ↗

4:45 PM ET Form 4
Insider Selling

Bicycle Therapeutics Director Robert Charles Swanton Sells $11.9K of Stock

Robert Charles Swanton, Director, sold 3,431 shares of Bicycle Therapeutics PLC at $3.47 a share, worth $11.9K in total on Oct 2, 2026. Shares held after the trade: 15,782 (-17.9%).

Value
$11.9K
Shares
3,431
Price
$3.47
Role
Director
Holding change
-17.9%
Trade date
Oct 2, 2026
4:45 PM ET Form 4
Insider Selling

Bicycle Therapeutics CEO Kevin Lee Sells $21.4K of Stock

Kevin Lee, CEO, sold 6,167 shares of Bicycle Therapeutics PLC at $3.47 a share, worth $21.4K in total on Oct 2, 2026. Shares held after the trade: 597,504 (-1.0%).

Value
$21.4K
Shares
6,167
Price
$3.47
Role
CEO
Holding change
-1.0%
Trade date
Oct 2, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.